Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study
- Pinato D. J.
- Aguilar-Company J.
- Ferrante D.
- Hanbury G.
- Bower M.
- Salazar R.
- Mirallas O.
- Sureda A.
- Plaja A.
- Cucurull M.
- Mesia R.
- Townsend S.
- Jackson A.
- Dalla Pria A.
- Newsom-Davis T.
- Handford J.
- Sita-Lumsden A.
- Apthorp E.
- Vincenzi B.
- Bertuzzi A.
- Brunet J.
- Lambertini M.
- Maluquer C.
- Pedrazzoli P.
- Biello F.
- Sinclair A.
- Bawany S.
- Khalique S.
- Rossi S.
- Rogers L.
- Murphy C.
- Belessiotis K.
- Carmona-Garcia M. C.
- Sharkey R.
- Garcia-Illescas D.
- Rizzo G.
- Perachino M.
- Saoudi-Gonzalez N.
- Doonga K.
- Fox L.
- Roldan E.
- Gaidano G.
- Ruiz-Camps I.
- Bruna R.
- Patriarca A.
- Martinez-Vila C.
- Cantini L.
- Zambelli A.
- Giusti R.
- Mazzoni F.
- Caliman E.
- Santoro A.
- Grosso F.
- Parisi A.
- Queirolo P.
- Aujayeb A.
- Rimassa L.
- Prat A.
- Tucci M.
- Libertini M.
- Grisanti S.
- Mukherjee U.
- Diamantis N.
- Fusco V.
- Generali D.
- Provenzano S.
- Gennari A.
- Tabernero J.
- Cortellini A.
- Evans J. S.
- Swallow J.
- Chung C.
- Patel M.
- Dettorre G.
- Ottaviani D.
- Chowdhury A.
- Merry E.
- Chopra N.
- Lee A. J.
- Sng C. C.
- Yu T.
- Shawe-Taylor M.
- Bain H. D.
- Wong Y. N. S.
- Galazi M.
- Benafif S.
- Dileo P.
- Earnshaw I.
- Patel G.
- Wu A.
- Soosaipillai G.
- Cooper L.
- Andaleeb R.
- Dolly S.
- Srikandarajah K.
- Jones E.
- Van Hemelrijck M.
- Moss C.
- Russell B.
- Chester J.
- Loizidou A.
- Piccart M.
- Cruz C. A.
- Reyes R.
- Segui E.
- Marco-Hernandez J.
- Viladot M.
- Eremiev S.
- Fort-Culillas R.
- Garcia I.
- Linan R.
- Roque Lloveras A.
- Harbeck N.
- Wuerstlein R.
- Henze F.
- Mahner S.
- Felip E.
- Pous A.
- D'Avanzo F.
- Scotti L.
- Krengli M.
- Marrari A.
- Delfanti S.
- Maconi A.
- Betti M.
- Tonini G.
- Di Fazio G. R.
- Tondini C.
- Chiudinelli L.
- Franchi M.
- Bertulli R.
- Baggi A.
- Tovazzi V.
- Ficorella C.
- Porzio G.
- Saponara M.
- Filetti M.
- Zoratto F.
- Paoloni F.
- Berardi R.
- Guida A.
- Bracarda S.
- Iglesias M.
- Sanchez de Torre A.
- Tagliamento M.
- Colomba E.
- Pommeret F.
DOIAbstract
Background The omicron (B.1.1.529) variant of SARS-CoV-2 is highly transmissible and escapes vaccine-induced immunity. We aimed to describe outcomes due to COVID-19 during the omicron outbreak compared with the prevaccination period and alpha (B.1.1.7) and delta (B.1.617.2) waves in patients with cancer in Europe.Methods In this retrospective analysis of the multicentre OnCovid Registry study, we recruited patients aged 18 years or older with laboratory-confirmed diagnosis of SARS-CoV-2, who had a history of solid or haematological malignancy that was either active or in remission. Patient were recruited from 37 oncology centres from UK, Italy, Spain, France, Belgium, and Germany. Participants were followed up from COVID-19 diagnosis until ...
Add to ORKG